DiaMedica Therapeutics DMAC
NASDAQ DMAC
$9.66 -0.01 (-0.10%)
At close: Nov 11, 2026 · 4:00 PM EST

DiaMedica Therapeutics (DMAC) Long-Term Deferred Tax (2020 - 2025)

Updated

Analysis

DiaMedica Therapeutics (DMAC) Long-Term Deferred Tax (2020 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 DiaMedica Therapeutics 521.46 Mn 311.42 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 42.41 Mn
Dec 31, 2024 34.18 Mn
Dec 31, 2023 28.04 Mn
Dec 31, 2022 22.74 Mn
Dec 31, 2021 19.39 Mn
Dec 31, 2020 16.27 Mn
API Access

DiaMedica Therapeutics Long-Term Deferred Tax API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-deferred-tax&ticker=DMAC&period=max&api_key=YOUR_API_KEY